• Corpus ID: 222408048

TPS-23: A NEW THIORIDAZINE DERIVATIVE.

@article{Dm1965TPS23AN,
  title={TPS-23: A NEW THIORIDAZINE DERIVATIVE.},
  author={Gallant Dm and Bishop Mp and Sprehe Dj},
  journal={Current Therapeutic Research-clinical and Experimental},
  year={1965},
  volume={7},
  pages={102}
}
11 Citations
A Clinical Evaluation of Mesoridazine in Mentally Retarded Patients
  • W. Zaleski
  • Chemistry
    Canadian Psychiatric Association journal
  • 1970
Mesoridazine,'? 2-methylsulf inyl-10[2'(N-methyl-piperidyl-2 ethyl-1'] phenothia­ zine is the side-chain sulfoxide derivative of thioridazinett. The pharmacological profile of the new drug is
The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
Mesoridazine (TPS-23) in chronic neurotic clinic patients.
[Clinical study of mesoridazine (TPS-23) with psychotic patients].
D,L-methionine-d, 1-sulfoximine effects in schizophrenic patients.
TEN CHRONIC schizophrenic patients and nine nonschizophrenic control subjects were givend,l-methionine- d , l-sulfoximine (MSO) orally. A tenth nonschizophrenic subject was given a placebo. The ten
...
1
2
...